• SENSEX 77,301.40
    383.55 (+0.50%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
Back

Corporate News

Dr. Lal PathLabs to review potential interim dividend at November board meeting
28-Oct-2026, 12:25

Dr. Lal PathLabs Limited will consider a second interim dividend, if any, on its equity shares for the financial year 2026-27 at a board meeting scheduled for November 04, 2026, alongside the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.